Data / Drug companies / Viatris Pharmaceuticals LLC
Viatris Pharmaceuticals LLC: 29 products in the FDA NDC directory, labeler code 65427
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Viatris Pharmaceuticals LLC (labeler code 65427) lists 29 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients, 14 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on October 28, 2025.
The request: Watch Viatris Pharmaceuticals LLC (FDA labeler code 65427): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65427
- Products in commercial distribution
- 29
- Packages
- 29
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 6, 1989
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 51.7% |
| Export only | 14 | 48.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 51.7% |
| Drugs for further processing | 14 | 48.3% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 15 | 51.7% |
| Tablet, film coated | 10 | 34.5% |
| Tablet, multilayer, extended release | 2 | 6.9% |
| Tablet | 2 | 6.9% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Prazosin hydrochloride | 65427-301 | Tablet | Export only | October 28, 2025 |
| Prazosin hydrochloride | 65427-300 | Tablet | Export only | October 28, 2025 |
| Azithromycin dihydrate | 65427-416 | Tablet, film coated | Export only | July 11, 2022 |
| Azithromycin dihydrate | 65427-306 | Tablet, film coated | Export only | July 11, 2022 |
| Atorvastatin calcium | 65427-258 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-257 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-256 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-255 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-158 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-157 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-156 | Tablet, film coated | Export only | November 21, 2019 |
| Atorvastatin calcium | 65427-155 | Tablet, film coated | Export only | November 21, 2019 |
| Linezolid | 65427-821 | Powder | Bulk ingredients | July 3, 2014 |
| Exemestane | 65427-030 | Powder | Bulk ingredients | July 3, 2014 |
| Fluconazole | 65427-025 | Powder | Bulk ingredients | July 3, 2014 |
| Tolterodine | 65427-022 | Powder | Bulk ingredients | July 3, 2014 |
| Tolterodine tartrate | 65427-020 | Powder | Bulk ingredients | July 3, 2014 |
| Doxazosin mesylate | 65427-018 | Powder | Bulk ingredients | July 3, 2014 |
| Parecoxib sodium | 65427-017 | Powder | Bulk ingredients | July 3, 2014 |
| Doxazosin mesylate | 65427-016 | Tablet, multilayer, extended release | Export only | July 3, 2014 |
| Azithromycin dihydrate | 65427-014 | Powder | Bulk ingredients | July 3, 2014 |
| Doxazosin mesylate | 65427-012 | Tablet, multilayer, extended release | Export only | July 3, 2014 |
| Varenicline | 65427-010 | Powder | Bulk ingredients | July 3, 2014 |
| Sertraline | 65427-009 | Powder | Bulk ingredients | July 3, 2014 |
| Latanoprost | 65427-007 | Powder | Bulk ingredients | July 3, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.